Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibody
US9403902B2 · kind B2 · utility
7Cited by
114References
9Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 3, 2008 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Jul 6, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/565
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions comprising highly specific and highly effective antibodies that specifically recognize and bind to specific epitopes from a range of amyloid-beta proteins. The antibodies of the present invention are particularly useful for the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system, particularly those ocular diseases associated with amyloid-beta-related pathological abnormalities/changes in the tissues of the visual system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.